亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Technical Aspects of Percutaneous Deep Venous Arterialization Using Off-the-Shelf Devices

医学 经皮 血运重建 外科 心脏病学 心肌梗塞
作者
Ivan Kuang Hsin Huang,Tatsuya Nakama,Shigeo Ichihashi,Uei Pua
出处
期刊:Journal of Endovascular Therapy [SAGE Publishing]
卷期号:31 (3): 350-359 被引量:3
标识
DOI:10.1177/15266028221127850
摘要

Purpose: Chronic limb-threatening ischemia (CLTI) represents the clinical end stage of lower extremity peripheral arterial disease (PAD). Although conventional open and endovascular revascularization options are available, some CLTI patients do not respond to these treatments, generally due to small vessel occlusive disease, with only limited or no clinical improvement achieved. This article aims to provide insights related to pertinent venous anatomy of the leg and below the ankle and a technical review of percutaneous deep venous arterialization (pDVA) creation using commonly-available devices. Technique: For patients with “no-option” CLTI, the risk of major amputation and mortality remains high. Although arterial revascularization remains the optimal treatment of CLTI, some patients with severely-diseased or gracile distal arteries have poor outcome. Deep venous arterialization (DVA), in a subset of patients with tibial anatomy amenable to DVA creation, represents the last-ditch attempt before these patients are deemed to have “no-hope” at limb salvage, and major amputation becomes necessary. Refinement in technique and advancement in device development have been shown to allow pDVA to be created with respectable outcomes for the “no-option” CLTI patient population. Conclusion: The pDVA has garnered increasing interest among endovascular specialists to further understand the anatomical and technical key points of this procedure, and it may yet prove to be a useful addition in the armamentarium in our battle against CLTI. Clinical Impact Percutaneous deep venous arterialisation provides another option in the treatment of challenging “no-option” CLTI patients, and off-the-shelf devices will allow this procedure to be performed in centers where dedicated devices are not available.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
7秒前
研究XPD的小麻薯完成签到,获得积分10
9秒前
李健的小迷弟应助haha采纳,获得10
12秒前
14秒前
15秒前
bkagyin应助科研通管家采纳,获得10
15秒前
小姑不在发布了新的文献求助30
16秒前
20秒前
21秒前
22秒前
阿拉丁神灯完成签到,获得积分10
26秒前
haha发布了新的文献求助10
27秒前
32秒前
田様应助小姑不在采纳,获得10
36秒前
41秒前
神勇尔蓝发布了新的文献求助10
47秒前
48秒前
tanrui完成签到,获得积分10
56秒前
1分钟前
在水一方应助haha采纳,获得10
1分钟前
华仔应助云宝采纳,获得10
1分钟前
1分钟前
可爱的函函应助ycliang采纳,获得10
1分钟前
Hulda发布了新的文献求助10
1分钟前
Faye发布了新的文献求助10
1分钟前
1分钟前
haha发布了新的文献求助10
1分钟前
1分钟前
1分钟前
小姑不在发布了新的文献求助10
1分钟前
慕青应助小姑不在采纳,获得20
1分钟前
研友_VZG7GZ应助小姑不在采纳,获得10
1分钟前
在水一方应助小姑不在采纳,获得10
1分钟前
科研通AI6.1应助小姑不在采纳,获得10
1分钟前
万能图书馆应助小姑不在采纳,获得10
1分钟前
Lucas应助小姑不在采纳,获得10
1分钟前
搜集达人应助小姑不在采纳,获得200
1分钟前
赘婿应助长情梦菡采纳,获得10
1分钟前
充电宝应助神勇尔蓝采纳,获得10
1分钟前
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Handbook of pharmaceutical excipients, Ninth edition 5000
Aerospace Standards Index - 2026 ASIN2026 3000
Polymorphism and polytypism in crystals 1000
Signals, Systems, and Signal Processing 610
Discrete-Time Signals and Systems 610
T/SNFSOC 0002—2025 独居石精矿碱法冶炼工艺技术标准 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 纳米技术 有机化学 物理 生物化学 化学工程 计算机科学 复合材料 内科学 催化作用 光电子学 物理化学 电极 冶金 遗传学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 6042384
求助须知:如何正确求助?哪些是违规求助? 7793025
关于积分的说明 16237142
捐赠科研通 5188246
什么是DOI,文献DOI怎么找? 2776328
邀请新用户注册赠送积分活动 1759412
关于科研通互助平台的介绍 1642887